Company intelligence / Profile preview

Othram

Spring, Texas, United Statesothram.com ↗

Ownership: Private
Development stage: Commercial

Overview

Othram has enabled the identification of hundreds of victims and suspects in cold cases across the United States since its founding. Its advanced DNA sequencing technology allows successful human ID from highly degraded or limited samples that were previously unsolvable by traditional methods. The company’s work has led to major breakthroughs in missing persons cases and criminal investigations, often providing closure to families after decades.

Therapeutic areas: OtherInfectious Diseases
Modalities: DNA sequencing technologyGenomic analysis platform (KinSNP®)Bioinformatics software workflows
Industry: Molecular Diagnostics

Partnerships

National Missing and Unidentified Persons System (NamUs)Australian Federal Police National DNA ProgramU.S. Bureau of Indian Affairs

Beyond the preview

Go deeper on Othram.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Othram.

Explore the full profile